US Food And Drug Administration Issues Equivalence Guideline For Biosimilars Producers 05/01/2017 by Intellectual Property Watch 1 Comment Biotherapeutic medicines are made out of living organisms and cannot be replicated. No generic medicines, which are exact copies of the reference product, can be made. The generic equivalent of a biotherapeutic would be biosimilars, which are highly similar products. The United States Food and Drug Administration has issued a guide to help producers to prove how close their biosimilars are to the biotherapeutics.
IP World Enters New Year With Major Shift Of People In Pharma, Copyright 22/12/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment As a new year dawns, a lot of movement has been observed in the pharmaceutical industry with new key players taking the lead. Meanwhile, new delegates are covering IP issues in Geneva, and coordination of regional groups at the World Intellectual Property Organization makes its usual yearly shift for 2017. The copyright industry also saw major changes, and law offices have been busy hiring new partners.
UNITAID Board Adopts Resolution On IP Flexibilities Under Trade Rules 16/12/2016 by Catherine Saez, Intellectual Property Watch 1 Comment The Executive Board of UNITAID yesterday adopted a resolution on the use of the intellectual property flexibilities enshrined in the global trading system allowing developing countries to facilitate access to affordable medicines.
Patents And Health Debate Brings Key WIPO Committee To Standstill 16/12/2016 by Catherine Saez, Intellectual Property Watch 1 Comment After a day spent in informal meetings to try to agree on what should be the future work of the World Intellectual Property Organization patent law committee, delegates had to admit defeat. The main point of contention, according to sources, was the request by developing countries that the committee work on the issue of patents and access to medicines, and address the recommendations of the United Nations Secretary-General’s High Level Panel on Access to Medicines. This request was met by blunt refusal by some developed countries as beyond the realm of the work of the committee.
Trademarks Promote Economic Growth In Latin America, Industry Study Says 16/12/2016 by Intellectual Property Watch Leave a Comment A new study by intellectual property trade associations analysed the correlation between trademarks and their economic impact on several Latin American countries. The study found that trademark registration is growing in the region and promotes economic growth.
Group Finds Discrepancies In Implementation Of Nagoya Protocol Between EU, Providers 15/12/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A new report by two civil society groups explores what they say are discrepancies between European Union and provider country laws implementing the Nagoya Protocol on genetic resources, which they say could lead to legal uncertainties for users and providers.
Idea Of A Multilateral Investment Court Makes Headway, Proponents Say 15/12/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The European Union and Canada held an informal meeting in Geneva this week to present a project for a multilateral investment court to handle global investor-state disputes, hoping to draw interest and questions by other country delegates, according to sources. Time will be needed to gain acceptance of the idea, they said, and the next opportunity will be at the January World Economic Forum in Davos.
Things Heat Up In WIPO Debate On Patents And Health 14/12/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization patent law committee this week became the latest venue for the global debate over the system to provide incentives to the pharmaceutical industry to find new medicines while ensuring all patients have access to those medicines. Most developing countries want the committee to discuss the recommendations of the United Nations Secretary-General’s High-Level Panel on Access to Medicines, while most developed countries disagree. The tone is rising, and the issue could come as a hurdle as countries decide the future work of the committee.
WIPO Patent Committee Asked To Discuss UN High Level Report On Access To Medicines 13/12/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization patent law committee is a unique international forum where discussions about the patent system are held. The committee meeting this week is a display of different views of developed and developing countries on how the patent system is expected to meet their needs.
A Look At The UNAIDS Board Debate On IP And Medicines; Outcome Fell Short For Some 12/12/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The discussion on intellectual property-related barriers to access to medicines was one of the most contentious points of the 39th meeting of the UNAIDS governing board last week. After hours of negotiations, the board agreed that the organisation will keep working on the issue. But developing countries and civil society would have preferred a stronger mandate, according to representatives.